DOI QR코드

DOI QR Code

Control of Femoral Cannulation with a ProGlide Pre-Closure Device during Cardiac Surgery: Is It Reliable?

  • Kim, Chang Hun (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Ju, Min Ho (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Lim, Mi Hee (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Lee, Chee-Hoon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine) ;
  • Je, Hyung Gon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Medical Research Institute, Pusan National University School of Medicine)
  • Received : 2021.01.19
  • Accepted : 2021.03.17
  • Published : 2021.06.05

Abstract

Background: The use of ProGlide as a percutaneous vascular closure device in cardiac surgery remains inconclusive. This study investigated the clinical outcomes of using ProGlide in the percutaneous cannulation of femoral vessels in adult cardiac surgery. Methods: From September 2017 to July 2018, 131 consecutive patients underwent femoral vessel cannulation during cardiac surgery. The ProGlide (Abbott Vascular Inc., Santa Clara, CA, USA) with percutaneous cannulation was used in 118 patients (mean age, 55.7±15.5 years). The accessibility of femoral cannulation was evaluated through preoperative computed tomography. For cannulation, sonography was routinely used. The postoperative ankle-brachial index (ABI) was used to evaluate femoral artery stenosis. Results: Of the 118 patients, 112 (94.9%) and 6 (5.1%) underwent minimally invasive cardiac surgery and median sternotomy, respectively. Most femoral cannulations were performed on the right side (98.3%) using 15F to 19F arterial cannulas. The technical success rate of cannulation with ProGlide was 99.2%, with no delayed bleeding or cannulation site-related complications during hospitalization. During follow-up, only 1 patient showed femoral artery stenosis with claudication and was treated with interventional balloon angioplasty. The postoperative ABI revealed no significant difference in functional stenosis between the cannulation and non-cannulation sides (n=86; cannulation vs. non-cannulation, 1.2±0.1 vs. 1.1±0). Conclusion: Percutaneous femoral cannulation with ProGlide was safe and feasible in adult cardiac surgery. This technique may be a good alternative option in patients requiring femoral vessel cannulation for cardiac surgery.

Keywords

References

  1. Chan EY, Lumbao DM, Iribarne A, et al. Evolution of cannulation techniques for minimally invasive cardiac surgery: a 10-year journey. Innovations (Phila) 2012;7:9-14. https://doi.org/10.1097/imi.0b013e318253369a
  2. Cakici M, Yazicioglu L, Baran C, et al. A retrospective analysis of surgical femoral artery closure techniques: conventional versus purse suture technique. Ann Vasc Surg 2017;44:103-12. https://doi.org/10.1016/j.avsg.2017.04.032
  3. Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochrane Database Syst Rev 2016;3:CD009541.
  4. Karaolanis G, Kostakis ID, Moris D, Palla VV, Moulakakis KG. Fascia suture technique and suture-mediated closure devices: systematic review. Int J Angiol 2018;27:13-22. https://doi.org/10.1055/s-0037-1620241
  5. Kodama A, Yamamoto M, Shimura T, et al. Comparative data of single versus double ProGlide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) Japanese multicenter registry. Catheter Cardiovasc Interv 2017;90:E55-62.
  6. Steppich B, Stegmuller F, Rumpf PM, et al. Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device. J Interv Cardiol 2018;31:223-9. https://doi.org/10.1111/joic.12459
  7. Ramponi F, Yan TD, Vallely MP, Wilson MK. Total percutaneous cardiopulmonary bypass with Perclose ProGlide. Interact Cardiovasc Thorac Surg 2011;13:86-8. https://doi.org/10.1510/icvts.2010.263715
  8. Moschovas A, Amorim PA, Nold M, et al. Percutaneous cannulation for cardiopulmonary bypass in minimally invasive surgery is associated with reduced groin complications. Interact Cardiovasc Thorac Surg 2017;25:377-83. https://doi.org/10.1093/icvts/ivx140
  9. Dall'Ara G, Santarelli A, Marzocchi A, et al. Vascular complications after balloon aortic valvuloplasty in recent years: incidence and comparison of two hemostatic devices. Catheter Cardiovasc Interv 2018; 91:E49-55.
  10. Barbash IM, Barbanti M, Webb J, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J 2015;36:3370-9. https://doi.org/10.1093/eurheartj/ehv417
  11. Nara Y, Watanabe Y, Kozuma K, et al. Incidence, predictors, and mid-term outcomes of percutaneous closure failure after transfemoral aortic valve implantation using an expandable sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] registry). Am J Cardiol 2017;119:611-7. https://doi.org/10.1016/j.amjcard.2016.11.009
  12. Zakko J, Scali S, Beck AW, et al. Percutaneous thoracic endovascular aortic repair is not contraindicated in obese patients. J Vasc Surg 2014;60:921-8. https://doi.org/10.1016/j.jvs.2014.04.051
  13. Hu G, Chen B, Fu W, et al. Predictors and treatments of ProGlide-related complications in percutaneous endovascular aortic repair. PLoS One 2015;10:e0123739. https://doi.org/10.1371/journal.pone.0123739